Cohort Dashboard

GP2’s mission is to further understand the genetic architecture of Parkinson’s disease (PD) through genotyping diverse participant groups and studying highly suspected monogenic forms of PD. In support of this mission, we continue to collect diverse cohorts from around the world through collaboration and openly sharing data, processes, and results. Explore the dashboard below to understand our milestones achieved so far, and continue to visit this page as data will be updated monthly.

Total Global Data

Unique Locations
0
Cohorts
0
Samples Expected
0
Samples Completed
0

Last Updated: April 23, 2024 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova

Showing 10 of 238 cohort studies.

Malaysian Parkinson's Genetics Cohort - UMKLM

University of Malaya | Kuala Lumpur, Malaysia
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

780 Completed out of 2,600 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

1,014 Completed out of 1,100 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

1,794 Completed out of 3,700 Expected
Ancestry Breakdown for Samples Completed
Show

Manchester Brain Bank

University of Manchester | Manchester, United Kingdom
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

3 Completed out of 7 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

123 Completed out of 96 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

126 Completed out of 103 Expected
Ancestry Breakdown for Samples Completed
Show

MD GAP - Edinburgh Brain Bank - University of Edinburgh

University of Edinburgh | Edinburgh, United Kingdom
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

4 Completed out of 15 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

172 Completed out of 20 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

176 Completed out of 35 Expected
Ancestry Breakdown for Samples Completed
Show

MD GAP - King's College London

King's College London | London, United Kingdom
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

98 Completed out of 10 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

58 Completed out of 10 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

156 Completed out of 20 Expected
Ancestry Breakdown for Samples Completed
Show

MD GAP - Newcastle Brain Bank - University of Newcastle

University of Newcastle | Newcastle, United Kingdom
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

56 Completed out of 120 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

70 Completed out of 0 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

126 Completed out of 120 Expected
Ancestry Breakdown for Samples Completed
Show

MD GAP - OXF

Oxford University | Oxford, United Kingdom
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 132 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 0 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 132 Expected

MD GAP - QSBB - University College London

University College London | London, United Kingdom
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

504 Completed out of 828 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

517 Completed out of 270 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

1,021 Completed out of 1,098 Expected
Ancestry Breakdown for Samples Completed
Show

MD GAP - South West Dementia Brain Bank - Southmead Hospital

Southmead Hospital | Bristol, United Kingdom
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 77 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 0 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 77 Expected

MD GAP - Victorian Brain Bank

The Florey Institute of Neuroscience and Mental Health | Parkville, Australia
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

15 Completed out of 21 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

23 Completed out of 0 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

38 Completed out of 21 Expected
Ancestry Breakdown for Samples Completed
Show

MIND Initiative

University of Pennsylvania | Philadephia, United States
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 2,200 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 0 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 2,200 Expected

Submit a Cohort

If you would like to collaborate with GP2, reach out to submit a cohort or get more information on how to become a member.

Request AMP® PD Data Set

As GP2 completes cohort genotyping, all data is shared through the secured AMP® PD platform. Register to request access to this data.

Discover GP2 Members from Around the Globe

Explore the organizational members that make our research possible through their collaboration and contribution of samples and data.